Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1986;21(Suppl 1):33S–39S. doi: 10.1111/j.1365-2125.1986.tb02851.x

α-Adrenergic receptors in human blood vessels

P van Brummelen, K Jie, P A van Zwieten
PMCID: PMC1400759  PMID: 2871855

Abstract

1 The evidence for the presence of postjunctional α1- and α2-adrenoceptor subtypes in human blood vessels is reviewed.

2 Experiments in healthy subjects are described that show that α1- as well as α2-adrenoceptor mediated vasoconstriction contribute to vascular smooth muscle tone and that adrenaline and noradrenaline have similar affinities for each subtype. In addition, evidence is presented for a preferential intrajunctional location of α1-adrenoceptors and a preferential extrajunctional location of α2-adrenoceptors in human blood vessels.

3 It is concluded that at present postjunctional α-adrenoceptors in human blood vessels can be classified as α1 and α2. Despite the fact that both subtypes mediate vasoconstriction, these receptors are likely to subserve different physiological functions.

Keywords: α-adrenoceptors, catecholamines, forearm blood flow, human blood vessels

Full text

PDF
33S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abboud F. M., Schmid P. G., Eckstein J. W. Vascular responses after alpha adrenergic receptor blockade: I. Responses of capacitance and resistance vessels to norepinephrine in man. J Clin Invest. 1968 Jan;47(1):1–9. doi: 10.1172/JCI105699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ariëns E. J., Simonis A. M. Physiological and pharmacological aspects of adrenergic receptor classification. Biochem Pharmacol. 1983 May 15;32(10):1539–1545. doi: 10.1016/0006-2952(83)90324-6. [DOI] [PubMed] [Google Scholar]
  3. Barcroft H., Bonnar W. M., Edholm O. G., Effron A. S. On sympathetic vasoconstrictor tone in human skeletal muscle. J Physiol. 1943 Jun 30;102(1):21–31. doi: 10.1113/jphysiol.1943.sp004010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bolli P., Erne P., Kiowski W., Amman F. W., Bühler F. R. The adrenaline-alpha 2-adrenoceptor-mediated vasoconstrictor axis. Clin Sci (Lond) 1985;68 (Suppl 10):141s–146s. doi: 10.1042/cs068s141. [DOI] [PubMed] [Google Scholar]
  5. Drew G. M., Whiting S. B. Evidence for two distinct types of postsynaptic alpha-adrenoceptor in vascular smooth muscle in vivo. Br J Pharmacol. 1979 Oct;67(2):207–215. doi: 10.1111/j.1476-5381.1979.tb08668.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Elliott H. L., Reid J. L. Evidence for postjunctional vascular alpha 2-adrenoceptors in peripheral vascular regulation in man. Clin Sci (Lond) 1983 Sep;65(3):237–241. doi: 10.1042/cs0650237. [DOI] [PubMed] [Google Scholar]
  7. Flavahan N. A., McGrath J. C. Are human vascular alpha-adrenoceptors atypical? J Cardiovasc Pharmacol. 1984 Jan-Feb;6(1):208–210. [PubMed] [Google Scholar]
  8. Goldberg M. R., Robertson D. Evidence for the existence of vascular alpha 2-adrenergic receptors in humans. Hypertension. 1984 Jul-Aug;6(4):551–556. doi: 10.1161/01.hyp.6.4.551. [DOI] [PubMed] [Google Scholar]
  9. Izzo J., Jr Cardiovascular hormonal effects of circulating norepinephrine. Hypertension. 1983 Sep-Oct;5(5):787–789. doi: 10.1161/01.hyp.5.5.787. [DOI] [PubMed] [Google Scholar]
  10. Jauernig R. A., Moulds R. F., Shaw J. The action of prazosin in human vascular preparations. Arch Int Pharmacodyn Ther. 1978 Jan;231(1):81–89. [PubMed] [Google Scholar]
  11. Jie K., van Brummelen P., Vermey P., Timmermans P. B., van Zwieten P. A. Identification of vascular postsynaptic alpha 1- and alpha 2-adrenoceptors in man. Circ Res. 1984 Apr;54(4):447–452. doi: 10.1161/01.res.54.4.447. [DOI] [PubMed] [Google Scholar]
  12. Kiowski W., Bühler F. R., van Brummelen P., Amann F. W. Plasma noradrenaline concentration and alpha-adrenoceptor-mediated vasoconstriction in normotensive and hypertensive man. Clin Sci (Lond) 1981 May;60(5):483–489. doi: 10.1042/cs0600483. [DOI] [PubMed] [Google Scholar]
  13. Kiowski W., Hulthén U. L., Ritz R., Bühler F. R. Alpha 2 adrenoceptor-mediated vasoconstriction of arteries. Clin Pharmacol Ther. 1983 Nov;34(5):565–569. doi: 10.1038/clpt.1983.216. [DOI] [PubMed] [Google Scholar]
  14. LOWE R. D., ROBINSON B. F. EFFECT OF DIFFERENTIAL ADRENERGIC BLOCKADE ON RESPONSE OF FOREARM BLOOD FLOW TO INFUSED CATECHOLAMINES. Clin Sci. 1964 Feb;26:81–87. [PubMed] [Google Scholar]
  15. Langer S. Z., Hicks P. E. Alpha-adrenoreceptor subtypes in blood vessels: physiology and pharmacology. J Cardiovasc Pharmacol. 1984;6 (Suppl 4):S547–S558. doi: 10.1097/00005344-198406004-00001. [DOI] [PubMed] [Google Scholar]
  16. Langer S. Z. Presynaptic regulation of the release of catecholamines. Pharmacol Rev. 1980 Dec;32(4):337–362. [PubMed] [Google Scholar]
  17. Langer S. Z. Sixth gaddum memorial lecture, National Institute for Medical Research, Mill Hill, January 1977. Presynaptic receptors and their role in the regulation of transmitter release. Br J Pharmacol. 1977 Aug;60(4):481–497. doi: 10.1111/j.1476-5381.1977.tb07526.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. McGrath J. C. Evidence for more than one type of post-junctional alpha-adrenoceptor. Biochem Pharmacol. 1982 Feb 15;31(4):467–484. doi: 10.1016/0006-2952(82)90147-2. [DOI] [PubMed] [Google Scholar]
  19. Moulds R. J., Jauernig R. A. Mechanism of prazosin collapse. Lancet. 1977 Jan 22;1(8004):200–201. doi: 10.1016/s0140-6736(77)91808-6. [DOI] [PubMed] [Google Scholar]
  20. Norman R. A., Jr, Coleman T. G., Dent A. C. Continuous monitoring of arterial pressure indicates sinoaortic denervated rats are not hypertensive. Hypertension. 1981 Jan-Feb;3(1):119–125. doi: 10.1161/01.hyp.3.1.119. [DOI] [PubMed] [Google Scholar]
  21. Paciorek P. M., Shepperson N. B. alpha 1-Adrenoceptor agonist activity of alpha 2-adrenoceptor antagonists in the pithed rat preparation. Br J Pharmacol. 1983 May;79(1):12–14. doi: 10.1111/j.1476-5381.1983.tb10488.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Starke K. Presynaptic receptors. Annu Rev Pharmacol Toxicol. 1981;21:7–30. doi: 10.1146/annurev.pa.21.040181.000255. [DOI] [PubMed] [Google Scholar]
  23. Thom S., Calvete J., Hayes R., Martin G., Sever P. Human vascular smooth muscle responses mediated by alpha 2 mechanisms in vivo and in vitro. Clin Sci (Lond) 1985;68 (Suppl 10):147s–150s. doi: 10.1042/cs068s147. [DOI] [PubMed] [Google Scholar]
  24. Timmermans P. B., van Zwieten P. A. alpha 2 adrenoceptors: classification, localization, mechanisms, and targets for drugs. J Med Chem. 1982 Dec;25(12):1389–1401. doi: 10.1021/jm00354a001. [DOI] [PubMed] [Google Scholar]
  25. van Brummelen P., Jie K., Vermey P., Timmermans P. B., van Zwieten P. A. Vascular alpha-adrenoceptors in man: interactions with adrenaline and noradrenaline. Clin Sci (Lond) 1985;68 (Suppl 10):151s–153s. doi: 10.1042/cs068s151. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES